nodes	percent_of_prediction	percent_of_DWPC	metapath
Phendimetrazine—Stomach ache—Salbutamol—chronic obstructive pulmonary disease	0.0533	0.0552	CcSEcCtD
Phendimetrazine—Blood pressure increased—Arformoterol—chronic obstructive pulmonary disease	0.024	0.0249	CcSEcCtD
Phendimetrazine—Blood pressure increased—Formoterol—chronic obstructive pulmonary disease	0.024	0.0249	CcSEcCtD
Phendimetrazine—Blood pressure increased—Salbutamol—chronic obstructive pulmonary disease	0.0226	0.0235	CcSEcCtD
Phendimetrazine—Abdominal pain upper—Aminophylline—chronic obstructive pulmonary disease	0.0209	0.0217	CcSEcCtD
Phendimetrazine—Tremor—Roflumilast—chronic obstructive pulmonary disease	0.0193	0.0201	CcSEcCtD
Phendimetrazine—Palpitations—Roflumilast—chronic obstructive pulmonary disease	0.0183	0.0189	CcSEcCtD
Phendimetrazine—Dysuria—Tiotropium—chronic obstructive pulmonary disease	0.0174	0.0181	CcSEcCtD
Phendimetrazine—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.0152	0.0158	CcSEcCtD
Phendimetrazine—Abdominal pain upper—Salbutamol—chronic obstructive pulmonary disease	0.015	0.0156	CcSEcCtD
Phendimetrazine—Flushing—Aminophylline—chronic obstructive pulmonary disease	0.0147	0.0152	CcSEcCtD
Phendimetrazine—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.0147	0.0152	CcSEcCtD
Phendimetrazine—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.0144	0.0149	CcSEcCtD
Phendimetrazine—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.0133	0.0138	CcSEcCtD
Phendimetrazine—Dysuria—Salbutamol—chronic obstructive pulmonary disease	0.0133	0.0138	CcSEcCtD
Phendimetrazine—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.0129	0.0134	CcSEcCtD
Phendimetrazine—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.0127	0.0131	CcSEcCtD
Phendimetrazine—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.0122	0.0127	CcSEcCtD
Phendimetrazine—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.0122	0.0126	CcSEcCtD
Phendimetrazine—Sweating—Salbutamol—chronic obstructive pulmonary disease	0.0121	0.0126	CcSEcCtD
Phendimetrazine—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.0115	0.012	CcSEcCtD
Phendimetrazine—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.0115	0.0119	CcSEcCtD
Phendimetrazine—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.0111	0.0116	CcSEcCtD
Phendimetrazine—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.011	0.0114	CcSEcCtD
Phendimetrazine—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.0107	0.0111	CcSEcCtD
Phendimetrazine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.0106	0.0109	CcSEcCtD
Phendimetrazine—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.0106	0.0109	CcSEcCtD
Phendimetrazine—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.0103	0.0107	CcSEcCtD
Phendimetrazine—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.0102	0.0105	CcSEcCtD
Phendimetrazine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.01	0.0104	CcSEcCtD
Phendimetrazine—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.00982	0.0102	CcSEcCtD
Phendimetrazine—Tremor—Formoterol—chronic obstructive pulmonary disease	0.00982	0.0102	CcSEcCtD
Phendimetrazine—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.00977	0.0101	CcSEcCtD
Phendimetrazine—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.00963	0.00998	CcSEcCtD
Phendimetrazine—Agitation—Formoterol—chronic obstructive pulmonary disease	0.00963	0.00998	CcSEcCtD
Phendimetrazine—Tremor—Montelukast—chronic obstructive pulmonary disease	0.00962	0.00997	CcSEcCtD
Phendimetrazine—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.00959	0.00994	CcSEcCtD
Phendimetrazine—Agitation—Montelukast—chronic obstructive pulmonary disease	0.00943	0.00978	CcSEcCtD
Phendimetrazine—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.00927	0.00961	CcSEcCtD
Phendimetrazine—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.00926	0.0096	CcSEcCtD
Phendimetrazine—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.00926	0.0096	CcSEcCtD
Phendimetrazine—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.0091	0.00943	CcSEcCtD
Phendimetrazine—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.00907	0.0094	CcSEcCtD
Phendimetrazine—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00906	0.0094	CcSEcCtD
Phendimetrazine—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00889	0.00921	CcSEcCtD
Phendimetrazine—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.00875	0.00907	CcSEcCtD
Phendimetrazine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00838	0.00869	CcSEcCtD
Phendimetrazine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.00835	0.00865	CcSEcCtD
Phendimetrazine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.00835	0.00865	CcSEcCtD
Phendimetrazine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00788	0.00817	CcSEcCtD
Phendimetrazine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00781	0.00809	CcSEcCtD
Phendimetrazine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00774	0.00802	CcSEcCtD
Phendimetrazine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00774	0.00802	CcSEcCtD
Phendimetrazine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.0077	0.00798	CcSEcCtD
Phendimetrazine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00769	0.00797	CcSEcCtD
Phendimetrazine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00758	0.00786	CcSEcCtD
Phendimetrazine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00743	0.0077	CcSEcCtD
Phendimetrazine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00732	0.00758	CcSEcCtD
Phendimetrazine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00732	0.00758	CcSEcCtD
Phendimetrazine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00731	0.00757	CcSEcCtD
Phendimetrazine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00704	0.0073	CcSEcCtD
Phendimetrazine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00702	0.00728	CcSEcCtD
Phendimetrazine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00701	0.00727	CcSEcCtD
Phendimetrazine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00691	0.00716	CcSEcCtD
Phendimetrazine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00676	0.00701	CcSEcCtD
Phendimetrazine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00676	0.00701	CcSEcCtD
Phendimetrazine—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.00669	0.00693	CcSEcCtD
Phendimetrazine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00668	0.00692	CcSEcCtD
Phendimetrazine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00664	0.00688	CcSEcCtD
Phendimetrazine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00662	0.00687	CcSEcCtD
Phendimetrazine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00639	0.00662	CcSEcCtD
Phendimetrazine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.0063	0.00653	CcSEcCtD
Phendimetrazine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00585	0.00607	CcSEcCtD
Phendimetrazine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00585	0.00607	CcSEcCtD
Phendimetrazine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00573	0.00594	CcSEcCtD
Phendimetrazine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00566	0.00586	CcSEcCtD
Phendimetrazine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00566	0.00586	CcSEcCtD
Phendimetrazine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00554	0.00574	CcSEcCtD
Phendimetrazine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00553	0.00573	CcSEcCtD
Phendimetrazine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00536	0.00555	CcSEcCtD
Phendimetrazine—Headache—Formoterol—chronic obstructive pulmonary disease	0.00536	0.00555	CcSEcCtD
Phendimetrazine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.00535	0.00555	CcSEcCtD
Phendimetrazine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00534	0.00554	CcSEcCtD
Phendimetrazine—Headache—Montelukast—chronic obstructive pulmonary disease	0.00525	0.00544	CcSEcCtD
Phendimetrazine—Tranylcypromine—CYP1A2—chronic obstructive pulmonary disease	0.00515	1	CrCbGaD
Phendimetrazine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00508	0.00527	CcSEcCtD
Phendimetrazine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00508	0.00527	CcSEcCtD
Phendimetrazine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00506	0.00525	CcSEcCtD
Phendimetrazine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00498	0.00516	CcSEcCtD
Phendimetrazine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.0048	0.00497	CcSEcCtD
Phendimetrazine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.00452	0.00469	CcSEcCtD
Phendimetrazine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.00448	0.00464	CcSEcCtD
Phendimetrazine—Flushing—Prednisone—chronic obstructive pulmonary disease	0.0044	0.00456	CcSEcCtD
Phendimetrazine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.00419	0.00434	CcSEcCtD
Phendimetrazine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.00389	0.00403	CcSEcCtD
Phendimetrazine—Agitation—Prednisone—chronic obstructive pulmonary disease	0.00379	0.00393	CcSEcCtD
Phendimetrazine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.00329	0.00341	CcSEcCtD
Phendimetrazine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.00325	0.00337	CcSEcCtD
Phendimetrazine—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.00321	0.00333	CcSEcCtD
Phendimetrazine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.00306	0.00318	CcSEcCtD
Phendimetrazine—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.00304	0.00316	CcSEcCtD
Phendimetrazine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.00293	0.00303	CcSEcCtD
Phendimetrazine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.0029	0.00301	CcSEcCtD
Phendimetrazine—Constipation—Prednisone—chronic obstructive pulmonary disease	0.00288	0.00298	CcSEcCtD
Phendimetrazine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.00275	0.00285	CcSEcCtD
Phendimetrazine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.00266	0.00276	CcSEcCtD
Phendimetrazine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.0023	0.00239	CcSEcCtD
Phendimetrazine—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.00223	0.00231	CcSEcCtD
Phendimetrazine—Headache—Prednisone—chronic obstructive pulmonary disease	0.00211	0.00219	CcSEcCtD
Phendimetrazine—Nausea—Prednisone—chronic obstructive pulmonary disease	0.002	0.00207	CcSEcCtD
Phendimetrazine—ADRA1B—Adrenoceptors—ADRB2—chronic obstructive pulmonary disease	0.00196	0.0649	CbGpPWpGaD
Phendimetrazine—ADRA1A—Adrenoceptors—ADRB2—chronic obstructive pulmonary disease	0.00174	0.0577	CbGpPWpGaD
Phendimetrazine—SLC6A2—Monoamine Transport—SLC6A4—chronic obstructive pulmonary disease	0.00117	0.0389	CbGpPWpGaD
Phendimetrazine—SLC6A3—Monoamine Transport—SLC6A4—chronic obstructive pulmonary disease	0.00104	0.0344	CbGpPWpGaD
Phendimetrazine—ADRA1B—Monoamine GPCRs—ADRB2—chronic obstructive pulmonary disease	0.000691	0.023	CbGpPWpGaD
Phendimetrazine—ADRA1A—Monoamine GPCRs—ADRB2—chronic obstructive pulmonary disease	0.000614	0.0204	CbGpPWpGaD
Phendimetrazine—ADRA1B—Amine ligand-binding receptors—ADRB2—chronic obstructive pulmonary disease	0.000581	0.0193	CbGpPWpGaD
Phendimetrazine—SLC6A2—NRF2 pathway—SOD3—chronic obstructive pulmonary disease	0.000574	0.0191	CbGpPWpGaD
Phendimetrazine—ADRA1A—Endothelin Pathways—EDN1—chronic obstructive pulmonary disease	0.000549	0.0182	CbGpPWpGaD
Phendimetrazine—ADRA1B—Monoamine GPCRs—HTR2A—chronic obstructive pulmonary disease	0.000541	0.018	CbGpPWpGaD
Phendimetrazine—ADRA1A—Amine ligand-binding receptors—ADRB2—chronic obstructive pulmonary disease	0.000516	0.0171	CbGpPWpGaD
Phendimetrazine—SLC6A3—NRF2 pathway—SOD3—chronic obstructive pulmonary disease	0.000508	0.0169	CbGpPWpGaD
Phendimetrazine—ADRA1A—Monoamine GPCRs—HTR2A—chronic obstructive pulmonary disease	0.00048	0.0159	CbGpPWpGaD
Phendimetrazine—ADRA1B—Amine ligand-binding receptors—HTR2A—chronic obstructive pulmonary disease	0.000454	0.0151	CbGpPWpGaD
Phendimetrazine—ADRA1B—AMPK Signaling—ADIPOQ—chronic obstructive pulmonary disease	0.000448	0.0149	CbGpPWpGaD
Phendimetrazine—SLC6A2—Monoamine Transport—IL1B—chronic obstructive pulmonary disease	0.000426	0.0141	CbGpPWpGaD
Phendimetrazine—SLC6A2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000422	0.014	CbGpPWpGaD
Phendimetrazine—SLC6A2—NRF2 pathway—SERPINA1—chronic obstructive pulmonary disease	0.000409	0.0136	CbGpPWpGaD
Phendimetrazine—ADRA1A—Amine ligand-binding receptors—HTR2A—chronic obstructive pulmonary disease	0.000404	0.0134	CbGpPWpGaD
Phendimetrazine—ADRA1A—AMPK Signaling—ADIPOQ—chronic obstructive pulmonary disease	0.000398	0.0132	CbGpPWpGaD
Phendimetrazine—SLC6A3—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000395	0.0131	CbGpPWpGaD
Phendimetrazine—SLC6A3—Monoamine Transport—IL1B—chronic obstructive pulmonary disease	0.000377	0.0125	CbGpPWpGaD
Phendimetrazine—SLC6A2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000376	0.0125	CbGpPWpGaD
Phendimetrazine—SLC6A3—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000374	0.0124	CbGpPWpGaD
Phendimetrazine—SLC6A2—NRF2 pathway—GCLC—chronic obstructive pulmonary disease	0.000374	0.0124	CbGpPWpGaD
Phendimetrazine—SLC6A3—NRF2 pathway—SERPINA1—chronic obstructive pulmonary disease	0.000362	0.012	CbGpPWpGaD
Phendimetrazine—SLC6A2—NRF2 pathway—TGFB2—chronic obstructive pulmonary disease	0.000354	0.0118	CbGpPWpGaD
Phendimetrazine—SLC6A2—NRF2 pathway—SLC6A4—chronic obstructive pulmonary disease	0.000348	0.0115	CbGpPWpGaD
Phendimetrazine—ADRA1A—Endothelin Pathways—NOS3—chronic obstructive pulmonary disease	0.000334	0.0111	CbGpPWpGaD
Phendimetrazine—SLC6A3—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000333	0.0111	CbGpPWpGaD
Phendimetrazine—SLC6A3—NRF2 pathway—GCLC—chronic obstructive pulmonary disease	0.000331	0.011	CbGpPWpGaD
Phendimetrazine—SLC6A3—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000322	0.0107	CbGpPWpGaD
Phendimetrazine—SLC6A3—NRF2 pathway—TGFB2—chronic obstructive pulmonary disease	0.000314	0.0104	CbGpPWpGaD
Phendimetrazine—SLC6A2—Monoamine Transport—TNF—chronic obstructive pulmonary disease	0.000309	0.0103	CbGpPWpGaD
Phendimetrazine—SLC6A3—Dopaminergic Neurogenesis—TGFB1—chronic obstructive pulmonary disease	0.000308	0.0102	CbGpPWpGaD
Phendimetrazine—SLC6A3—NRF2 pathway—SLC6A4—chronic obstructive pulmonary disease	0.000308	0.0102	CbGpPWpGaD
Phendimetrazine—SLC6A3—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000303	0.0101	CbGpPWpGaD
Phendimetrazine—ADRA1B—AMPK Signaling—LEP—chronic obstructive pulmonary disease	0.000279	0.00925	CbGpPWpGaD
Phendimetrazine—SLC6A3—Monoamine Transport—TNF—chronic obstructive pulmonary disease	0.000274	0.00909	CbGpPWpGaD
Phendimetrazine—SLC6A2—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	0.000262	0.00871	CbGpPWpGaD
Phendimetrazine—SLC6A2—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	0.000259	0.00859	CbGpPWpGaD
Phendimetrazine—ADRA1A—AMPK Signaling—LEP—chronic obstructive pulmonary disease	0.000247	0.00822	CbGpPWpGaD
Phendimetrazine—SLC6A3—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000247	0.0082	CbGpPWpGaD
Phendimetrazine—SLC6A2—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	0.000241	0.008	CbGpPWpGaD
Phendimetrazine—SLC6A3—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	0.000232	0.00771	CbGpPWpGaD
Phendimetrazine—SLC6A3—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	0.000229	0.00761	CbGpPWpGaD
Phendimetrazine—SLC6A3—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	0.000213	0.00709	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.000213	0.00707	CbGpPWpGaD
Phendimetrazine—ADRA1B—Calcium Regulation in the Cardiac Cell—ADRB2—chronic obstructive pulmonary disease	0.000207	0.00688	CbGpPWpGaD
Phendimetrazine—ADRA1B—LPA receptor mediated events—CXCL8—chronic obstructive pulmonary disease	0.000197	0.00653	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.000189	0.00628	CbGpPWpGaD
Phendimetrazine—ADRA1A—Calcium Regulation in the Cardiac Cell—ADRB2—chronic obstructive pulmonary disease	0.000184	0.00611	CbGpPWpGaD
Phendimetrazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.000182	0.00605	CbGpPWpGaD
Phendimetrazine—ADRA1B—LPA receptor mediated events—MMP9—chronic obstructive pulmonary disease	0.000178	0.00591	CbGpPWpGaD
Phendimetrazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.000162	0.00538	CbGpPWpGaD
Phendimetrazine—ADRA1B—G alpha (q) signalling events—EDN1—chronic obstructive pulmonary disease	0.000154	0.00512	CbGpPWpGaD
Phendimetrazine—ADRA1B—LPA receptor mediated events—EGFR—chronic obstructive pulmonary disease	0.000144	0.00477	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000139	0.00461	CbGpPWpGaD
Phendimetrazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	0.000138	0.00458	CbGpPWpGaD
Phendimetrazine—ADRA1A—G alpha (q) signalling events—EDN1—chronic obstructive pulmonary disease	0.000137	0.00455	CbGpPWpGaD
Phendimetrazine—ADRA1B—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	0.000135	0.00448	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.000133	0.00443	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000123	0.00409	CbGpPWpGaD
Phendimetrazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	0.000123	0.00407	CbGpPWpGaD
Phendimetrazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	0.000121	0.00401	CbGpPWpGaD
Phendimetrazine—ADRA1A—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	0.00012	0.00398	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.000119	0.00394	CbGpPWpGaD
Phendimetrazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000114	0.0038	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000114	0.00378	CbGpPWpGaD
Phendimetrazine—ADRA1B—AMPK Signaling—TP53—chronic obstructive pulmonary disease	0.000114	0.00377	CbGpPWpGaD
Phendimetrazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	0.000107	0.00356	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000104	0.00346	CbGpPWpGaD
Phendimetrazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000102	0.00339	CbGpPWpGaD
Phendimetrazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000102	0.00337	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000101	0.00335	CbGpPWpGaD
Phendimetrazine—ADRA1A—AMPK Signaling—TP53—chronic obstructive pulmonary disease	0.000101	0.00335	CbGpPWpGaD
Phendimetrazine—SLC6A2—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	9.82e-05	0.00326	CbGpPWpGaD
Phendimetrazine—SLC6A2—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	9.78e-05	0.00325	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	9.73e-05	0.00323	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	9.27e-05	0.00308	CbGpPWpGaD
Phendimetrazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	9.07e-05	0.00301	CbGpPWpGaD
Phendimetrazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	8.94e-05	0.00297	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	8.84e-05	0.00293	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	8.71e-05	0.00289	CbGpPWpGaD
Phendimetrazine—SLC6A3—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	8.7e-05	0.00289	CbGpPWpGaD
Phendimetrazine—SLC6A3—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	8.67e-05	0.00288	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	8.64e-05	0.00287	CbGpPWpGaD
Phendimetrazine—SLC6A2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	8.28e-05	0.00275	CbGpPWpGaD
Phendimetrazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	7.94e-05	0.00264	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	7.85e-05	0.00261	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	7.84e-05	0.0026	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	7.78e-05	0.00258	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	7.73e-05	0.00257	CbGpPWpGaD
Phendimetrazine—SLC6A3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	7.33e-05	0.00244	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	7.12e-05	0.00237	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	6.97e-05	0.00231	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	6.91e-05	0.0023	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	6.89e-05	0.00229	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	6.81e-05	0.00226	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	6.33e-05	0.0021	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	6.12e-05	0.00203	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	6.05e-05	0.00201	CbGpPWpGaD
Phendimetrazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	5.52e-05	0.00183	CbGpPWpGaD
Phendimetrazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	5.45e-05	0.00181	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	5.22e-05	0.00173	CbGpPWpGaD
Phendimetrazine—SLC6A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.97e-05	0.00165	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	4.92e-05	0.00163	CbGpPWpGaD
Phendimetrazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	4.9e-05	0.00163	CbGpPWpGaD
Phendimetrazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	4.84e-05	0.00161	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	4.64e-05	0.00154	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	4.47e-05	0.00148	CbGpPWpGaD
Phendimetrazine—SLC6A3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.4e-05	0.00146	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	4.4e-05	0.00146	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	4.37e-05	0.00145	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	4.21e-05	0.0014	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	4.2e-05	0.0014	CbGpPWpGaD
Phendimetrazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	4.19e-05	0.00139	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	3.99e-05	0.00133	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	3.97e-05	0.00132	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	3.91e-05	0.0013	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	3.85e-05	0.00128	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	3.74e-05	0.00124	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	3.73e-05	0.00124	CbGpPWpGaD
Phendimetrazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	3.72e-05	0.00124	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	3.55e-05	0.00118	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	3.49e-05	0.00116	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	3.42e-05	0.00113	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	3.1e-05	0.00103	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	3.08e-05	0.00102	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.86e-05	0.00095	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.73e-05	0.000908	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.64e-05	0.000877	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.54e-05	0.000844	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.38e-05	0.000789	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.36e-05	0.000783	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.34e-05	0.000779	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.16e-05	0.000717	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.14e-05	0.000712	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.11e-05	0.000701	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.09e-05	0.000696	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.06e-05	0.000685	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.92e-05	0.000637	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.92e-05	0.000637	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.9e-05	0.000632	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.83e-05	0.000609	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.7e-05	0.000566	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.58e-05	0.000524	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.51e-05	0.0005	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.44e-05	0.000477	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.4e-05	0.000465	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.34e-05	0.000444	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.28e-05	0.000424	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.27e-05	0.000423	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.21e-05	0.000403	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.15e-05	0.000383	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.13e-05	0.000376	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.08e-05	0.000358	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.04e-05	0.000344	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.02e-05	0.00034	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	9.5e-06	0.000316	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	9.32e-06	0.000309	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	9.2e-06	0.000305	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	8.44e-06	0.00028	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	8.28e-06	0.000275	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	7.82e-06	0.00026	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	7.16e-06	0.000238	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	6.95e-06	0.000231	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.36e-06	0.000211	CbGpPWpGaD
